Clinical Trials Directory

Trials / Completed

CompletedNCT04569045

Evaluate the Safety and Effectiveness of Sodium Hyaluronate When Used for the Correction of Nasolabial Folds

A Randomized, Within-subject Controlled Clinical Study to Evaluate the Safety and Effectiveness of Pain Relief of Modified Sodium Hyaluronate Gel for Injection When Used for the Correction of Moderate or Severe Nasolabial Folds

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
SciVision Biotech Inc. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to evaluate the safety and effectiveness of pain relief of modified sodium hyaluronate gel for injection when used for the correction of moderate or severe nasolabial folds.

Detailed description

One hundred and thirty patients were enrolled and there two sides of nasolabial folds (NLF) were randomized to receive HA with lidocaine or HA. The primary outcome was immediate visual analogue scale (VAS) of pain evaluated after injection for both NLF sides. Secondary outcomes including VAS pain, wrinkle severity rating scale (WSRS), global aesthetic improvement scale (GAIS) and AE were observed at 1, 3, 6, 9, 12 follow-ups.

Conditions

Interventions

TypeNameDescription
DEVICEHA+Lidocaine20 mg
DEVICEHA20 mg

Timeline

Start date
2020-08-20
Primary completion
2020-12-04
Completion
2021-12-10
First posted
2020-09-29
Last updated
2022-02-25

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT04569045. Inclusion in this directory is not an endorsement.